2016 annual financial data
Theravance Biopharma 2016 Operating margin
Direct answer
Operating margin was -370.96%.
Operating income was -180,467,000 USD and net income was -190,669,000 USD.
Operating cash flow was -98,989,000 USD.
Get free Theravance Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 48,648,000 USD
- Operating income
- -180,467,000 USD
- Net income
- -190,669,000 USD
- Operating cash flow
- -98,989,000 USD